SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-074130
Filing Date
2024-06-24
Accepted
2024-06-24 07:25:23
Documents
19
Period of Report
2024-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417848d3_8k.htm   iXBRL 8-K 41261
2 EXHIBIT 4.1 tm2417848d3_ex4-1.htm EX-4.1 78329
3 EXHIBIT 5.1 tm2417848d3_ex5-1.htm EX-5.1 10664
4 EXHIBIT 10.1 tm2417848d3_ex10-1.htm EX-10.1 133821
5 EXHIBIT 10.2 tm2417848d3_ex10-2.htm EX-10.2 101298
6 EXHIBIT 99.1 tm2417848d3_ex99-1.htm EX-99.1 12271
7 GRAPHIC tm2417848d3_ex99-1img001.jpg GRAPHIC 15025
  Complete submission text file 0001104659-24-074130.txt   665658

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA trda-20240624.xsd EX-101.SCH 3018
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20240624_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20240624_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2417848d3_8k_htm.xml XML 3807
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 241062058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)